A living ‘microbial ink’ has been developed by a research team at Harvard University and Harvard Medical school, which can be 3D printed. One of the living materials generated from the ink has been designed to release an anti-cancer drug on demand.
A living ‘microbial ink’ has been developed by a research team at Harvard University and Harvard Medical school, which can be 3D printed. One of the living materials generated from the ink has been designed to release an anti-cancer drug on demand.